Patients who had HbA1c > or = 7.0 % , fasting plasma glucose ( FPG ) > or = 140 mg/dl , and C-peptide > 1 ng/ml were randomized to receive placebo or 7.5 , 15 , 30 , or 45 mg pioglitazone administered once a day for 26 weeks .
